To decipher the mechanism underlying the covalent binding of N-phenyl-N'-(2-chloroethyl)urea (CEU) to the colchicine-binding site on II-tubulin and to design new and selective antimitotic drugs, we developed 3D quantitative structure-activity relationships (3D-QSAR) models using CoMFA and CoMSIA analyses. The present study correlates the cell growth inhibition activities of 56 structurally related CEU derivatives to several physicochemical parameters representing steric, electrostatic, and hydrophobic fields. Both
Introduction
Microtubules are ubiquitous structures in eukaryotic cells and are involved in a wide range of cellular functions. Microtubules are composed of alternating -and -tubulin heterodimers, this dynamic structure rapidly assembles and disassembles depending on the cell's needs. 1 Tubulin is a major target for many anticancer drugs, clinically used or in development, because it is a key element in the cellular division process. There are three major binding sites identified on the tubulin heterodimers: the taxus-, the vinca-and the colchicinoid binding sites. Drugs acting in the taxus (e.g., paclitaxel 2 ) and the vinca (e.g., vincristine 3 ) binding sites are very important in the management of several cancers such as ovarian, breast, and prostrate cancers. 4 Unfortunately, several chemoresistance mechanisms in tumor cells impede the treatment of such cancers. 5 Thus, the research to find new antimicrotubule agents exhibiting optimal biopharmaceutical and pharmacological properties while dodging chemoresistance is the focus of numerous academic and industrial groups. Scientists have been focusing their efforts for several decades on the development of drugs acting on the colchicine-binding site (C-BS) such as indanocine, 7 curacin, 8 and 3-aminobenzophenone. 9 Drugs binding to the C-BS such as combretastatin A-4 have a great potential for the treatment of cancer (figure 1). 10 Among the new drugs acting on C-BS, our laboratory has developed in the past decade a novel class of antimitotics called N-phenyl-N'-(2-chloroethyl)ureas (CEU). 11 CEU are protein monoalkylating agents that covalently bind via the N'-(2-chloroethyl)urea moiety to the Glu 198 residue, an amino acid adjacent to the colchicine-binding site. 12 CEU do not alkylate most powerful nucleophilic cellular entities such as DNA, glutathione, or glutathione reductase, unlike most clinically relevant alkylating agents. 13 CEU exhibit cell growth inhibition (IC50) on numerous cancer cell lines and on various chemoresistant tumor cell lines (e.g., CEM/VLB500, LoVo, HT-29, CHO). [14] [15] [16] Moreover, CEU block efficiently angiogenesis and tumor growth in three distinct animal models: the Matrigel TM plug assay, the CT-26 tumor growth assay in mice, and the chick chorioallantoic membrane tumor assay, respectively. 13 On the basis of the apparent innocuousness of CEU and on their specific biodistribution to organs of the gastrointestinal tract, CEU represent a promising new class of anticancer drugs for the treatment of colorectal cancers. 13, 17, 18 Many structure-activity relationship studies were conducted to optimize the biopharmaceutical and the pharmacological properties of CEU.
14, 15 These studies showed that: (i) the modification of the urea group by a carbamate or a thiourea decreased the growth inhibition activity, (ii) the presence of an alkyl chain, an halogen, or a polycyclic group substituted at position 3 or 4 of the phenyl ring is essential to the inhibitory activity, and (iii) the introduction of a R-methyl group instead of a S isomer in position 2 of the chloroethyl moiety increased the activity of the drug, while the insertion of an alkyl group in position 2 of the phenyl ring abrogated the cytotoxic activity.
In this paper, we assessed the A and B moieties of the pharmacophore and the biofunctional group, part C of CEU (figure 2). The aim of this investigation was to determine the most essential structural elements to optimize the antimitotic activity of CEU. The CoMFA and CoMSIA models were compared to the colchicine-binding site model realized from the X-ray structure at 3.58 Å of the stathminlike domain complex (PDB code 1SA0) of the tubulin-colchicine. 19 2 Computational details
Data sets and biological activity
Training set and test set for the QSAR analyses were taken from three samples data sets. [14] [15] [16] Some structures were rejected because they were active on another protein. For example, 1-(2-chloroethyl)-3-[4-(cyclohexyl)phenyl]urea acts on thioredoxin isoform 1 and 1-(2-chloroethyl)-3-(4-heptylphenyl)urea acts on the mitochondrial voltage-dependent anion channel. 20 In the case where the data were not obtained from the same experiment, they were normalized by a linear regression to the experimental value of 1-(4-tertbutylphenyl)-3-(2-chloroethyl)urea (42) published by Mounetou et al. 14 to ensure that there is consistency between cell lines (HT-29) in determining the biological activities. 21 When the IC50 of CEU on HT-29 cells was unavailable, the IC50 was obtained from MDA-MB-231; cells that were shown to give IC50 in the same order of magnitude. In addition, the mechanism of action of CEU is the same on both cell lines. 13 The IC50 obtained from MDA-MB-231 cells were normalized by a linear regression based on compound 42.
Fiftysix compounds were selected for the training set, and nine compounds were selected for the test set and were different from those of the training set. The molecules of the test set represent 16% of the training set, which is a good ratio to validate a molecular model.
The strategy for the selection of the compounds included in the test set was a random selection of a family of compounds that exhibited a wide range of inhibitory activities. The structure and the IC50 values of the compounds of the training and the test sets are listed in Table 1 . 
Template selection
In the development of 3D-QSAR models, the choice of the template conformation is important to provide the illustration of a reliable pharmacophore model. X-ray structure of tubulin complexed with colchicine was available (PDB 1SA0). 19 CEU is hydrophobic in nature and has a mainly rigid molecular frame. However, CEU does not exhibit the same mechanism of action (acylation of Glu 198 ) on tubulin when compared to colchicine (anchoring Cys 239 and Cys 354 ) 22 that was co-crystallized with tubulin in the X-ray structure. 19 CoMFA and CoMSIA experiments not only provide additional tools to design new CEU but also comparative tools to validate whether the X-ray structure is appropriate to the modelization using CEU. Compound 1-(1-chloropropan-2-yl)-3-(4-iodophenyl)urea (22) was selected as a molecular template because it is the most potent compound of the series, being active in vitro and in vivo on a murine colon carcinoma. 17, 18 This compound was chosen mainly for its importance as a lead compound for the pharmacomodulation of CEU. It has been described in the literature 23, 24 that a combination of experimental data and theoretical calculations may improve statistical values of a 3D-QSAR analysis but at the present time there are no experimental NMR nor other experimental data to confirm the structure of the active conformation. The optimal number of components (ONC) varied according to two different parameters, namely, optimum q 2 and ONC with 5 components and optimum q 2 with 15 components, to assess their effect on the determination of valid 3D-QSAR models. Initial structures were generated using the cleanup procedure within SYBYL and energy-minimized using MAXIMIN2 (Powell method, 2000 iterations, and 0.05 kcal mol -1 Å -1 energy gradient convergence criteria). It is known that the conformation representing the global minimum of the ligand may not bind to the receptor and some degree of torsional freedom is required for the drug to adapt to the receptor-binding site to yield a drug-receptor complex of lower energy. 25 But in our case, we have mainly rigid structures to limit the possible active conformations and the 'minimum' energy conformation resulting from a MAXIMIN2 procedure is an excellent starting point to identify possible active candidate conformations for the compound of interest.
Structure alignment
All compounds of the training and the test sets contained a common fragment: a substituted phenyl methyl urea group ( Figure 3 ). This structure was mainly rigid (limited number of possible conformations) and it was chosen to align all molecules of the training and the test sets. Thus, that frame structure was introduced in the database and the database was aligned using command 'align database'. Figure 3 Template alignment of the training set and the test set database.
Results and discussion
A data set of 56 CEU derivatives for the training set and 9 CEU for the test set was used with a wide spectrum of activities against tumor cells. The test set was used to determine the accuracy of the model. The training set and the test set were aligned to derive both the conventional CoMFA and CoMSIA models as shown in Figure 4 . Thus, a total of 4 models were generated with two different ONC (10 and 4 components). The cross- 
CoMFA analysis
By use of the default CoMFA settings, which included steric and electrostatic fields and molecular weight (MW) parameters, cross-validated coefficient (q 2 ) 0.743 with 10
ONC was observed (model A) ( Table 2 ). With the same fields without MW parameter, cross-validated coefficient (q 2 ) 0.664 with 4 ONC was observed (model B) ( Table 2 ). The choice of the CoMFA options described below was based on maximizing the q 2 value.
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The statistical parameters associated with all models are shown in Table 2 . The predicted pIC50 values for each training set of compounds and the residual values are given in Table   3 . that an outlier is based on the "normalization" of IC50 obtained from MDA-MB-231 tumor cells. Consequently, the hypothesis that outliers could be related to the use of two cell lines to determine the IC50 was ruled out. contours in the CoMFA electrostatic field contours also represent 80% and 20% level contributions (Figure 6 ), respectively. CoMSIA analyses were selected also to construct contour maps (Figure 7 ). In the CoMSIA electrostatic field, the red (negative charge favorable) and blue (negative charge unfavorable) contours represent 80% and 20% level contributions, respectively. In the steric field, the green (sterically favorable) and yellow (sterically unfavorable) contours represent 80% and 20% level contributions, respectively.
CoMFA and CoMSIA contour maps
In the hydrophobic field, gray (favorable) and magenta (unfavorable) represent 80% and 20% level contributions, respectively. The contour maps of the CoMFA models were distributed in the entire molecule. 
Part C
The part C was the most studied region in these models. In each CoMFA model, a red unfavourable electrostatic region far from the phenyl ring (a chain length >7 atoms)
suggests that the presence of a negatively charged group decreases the antiproliferative activity of CEU. In addition, substituent on the phenyl ring having an alkyl chain longer than 7 carbon atoms seems to decrease also the antiproliferative activity of CEU (e.g., compounds 18 and 19). In the CoMFA model A, a blue favorable electrostatic region near the phenyl ring and the iodine atom explains the increased antiproliferative activity of CEU substituted by an iodine atom instead of a chlorine or a bromine atom. This increase of the antiproliferative activity of iodo-substituted CEU might be explained also by changes in the Van der Waals interactions of the phenyl ring that becomes a weaker electron-acceptor when substituted by a chlorine or a bromine atom. In the same region, there is a favorable green steric bulky region in each model that may explain the increased antiproliferative activity of CEU substituted with a branched lower alkyl chain or an aromatic ring. Figure 7 Contour maps generated with the CoMSIA model based on growth inhibition: (A) model generated with 10 components and (B) model generated with 4 components. Colorcoding is as follows: blue indicates that a positive charge favors high affinity, whereas red indicates that a positive charge does not favor high affinity. Yellow indicates regions where bulky groups decrease activity, whereas green indicates regions where bulky groups increase activity. The gray color indicates regions where hydrophobic groups increase the cytotoxicity of CEU, whereas magenta indicates regions where hydrophobic groups decrease the biological activity.
The contour maps of CoMSIA models also indicate features in part A-C. CoMSIA model C is based on three parameters: steric, electrostatic, and hydrophobic fields while the CoMSIA model D takes into account the hydrophobic field only.
Hydrophobic field
Hydrophobic field had equivalent regions in two CoMSIA models. For these reasons, we have described the hydrophobic field for both models. In part A, the weak antiproliferative activity of compounds 49, 50, 54, 55 and 56 that are substituted by ethyl or propyl groups is depicted by the gray favourable hydrophobic region near the chlorine atom. The presence of R-ethyl, S-methyl, and S-ethyl groups decreased the activity and generated a magenta unfavourable hydrophobic region around the ethyl region. The presence of a methyl or ethyl group at position 2 or 6 of the phenyl ring in part B abrogates the antiproliferative activity and consequently induces two magenta unfavourable regions.
In part C, compounds 18 and 19 with a chain length of 10 and 12 carbon atoms, respectively, are inactive. Consequently, a magenta unfavorable region was created in this part. A good activity of lower alkyl chain substituents at position 4 of the phenyl ring has generated a gray favorable hydrophobic region.
Steric field
For the steric field of CoMSIA model C, the weak activity of the propyl group in part A produced a green favorable steric region. Unexpectedly, there was no unfavorable steric region in the urea region of the CEU. This unexpected result might be related to the unfavourable hydrophobic region in this area. Similarly to the CoMFA model, the CoMSIA model generated a yellow unfavorable steric in part B that explains the biological inactivity of compounds 1, 3-5 in training set and compound 57 in the test set bearing a methyl or ethyl group at the 2 or 6 position of the phenyl ring. Moreover, in part C, a good antiproliferative activity of CEU substituted by lower alkyl chains produced a green favorable region in this area. As aforementioned, model C showed two sterically green favorable regions in proximity to the iodo group and generated two sterically yellow unfavorable regions at the same chain length.
Electrostatic field
The presence of a 3-chloropropyl group, that decreases the pharmacological activity of the drugs, has generated two unfavorable red electrophilic regions on both sides of the chlorine atom. The presence of the chlorine atom in part A and the urea group has generated two blue favorable electrophilic regions in both areas. There are also two red regions surrounding the urea moiety suggesting the importance of a negatively charged group (acceptor group) such as an urea for the biological activity. Figure 8 Alignment of the training-set into the colchicine-binding site to highlight the similarities between CoMSIA and CoMFA models. Important amino acids for the mechanism(s) of action such as Glu 198 , Cys 239 and guanosine triphosphate are also showed. The color of the pocket contours represents the hydrophobic (brown) and electrostatic (blue) fields, respectively. The -helices are in red, the -sheets in blue and the protein backbone is in yellow.
The comparison of our CoMFA and CoMSIA models with the C-BS model published by Ravelli et al. 19 exposed several similarities between these models. The experiments conducted on tumor cell growth showed that the chlorine atom on the 2-chloroethyl amino moiety of CEU is prerequisite for the acylation of Glu 198 . 12 In that context, CEU were docked in the C-BS as displayed in Figure 8 to highlight Glu 198 that is located at the end of the hydrophobic pocket adjacent to the C-BS and involved in the mechanism of action of CEU. All together our experiments using molecular modeling (crankshaft method) and molecular pharmacology methodologies are in good agreement with the X-ray structure described by Ravelli. 
Conclusion
In this study, we have investigated 3D-QSAR models of CEU. Predictive CoMFA electrostatic fields, and molecular weight parameters, while the steric, electrostatic, and hydrophobic fields were the most important regions to obtain the best CoMSIA model. Few similarities were established between our CoMFA and CoMSIA models and X-ray structure models: (1) a chlorine atom is essential to the acylation of Glu 198 and is also necessary to the cell growth inhibitory activity; (2) a bulky group around the pharmacophore confirms the tightness of the binding pocket; (3) an electrostatic favorable region near the urea moiety is necessary to stabilize the CEU before the acylation; (4) an important unfavorable steric region at the end of a chain length of 7 carbon atoms showed that bulky groups decrease the activity at that point; (5) an important favourable electrostatic region around the phenyl ring and iodo group showed that weak electroattractive groups improve the antiproliferative activity of CEU. The derived models in this study explain the observed variance in the activity of CEU. They show a high level of similitude with the models obtained by X-ray structure 19 and they establish that their X-ray model is applicable for the particular mechanism of acylation of CEU. They help also to understand the mechanism of action of CEU activity on II-tubulin, and provide important insights into structural variations that may lead to the design of new antitubulin agents exhibiting higher selectivity toward the colchicine-binding site.
Experimental

CoMFA
The initial CoMFA model was calculated using the SYBYL 7.0 molecular modeling software. For the calculation of charges, the Gasteiger-Hückel method was used as 
CoMSIA
CoMSIA analysis was performed using the QSAR module in SYBYL 
PLS analysis
The conventional CoMFA and CoMSIA descriptors derived above were used as explanatory variables, and pIC50 (-logIC50) values were used as the target variable in PLS regression analyses to derive 3D-QSAR models using the implementation in the SYBYL package. The predictive value of the models was evaluated by leave-one-out (LOO) crossvalidation with SAMPLS. The cross-validated coefficient, q 2 , was calculated using: procedure was used to validate each model. This is a procedure in which n random selections out of the original set of n objects are performed several times (100-times was used to have good statistical information) to simulate different samplings from a larger set of objects. In each run some objects may not be included in the PLS analysis (same method to determine the q 2 ), whereas some others might be included more than once. Confidence intervals for each term can be estimated from such a procedure, giving an independent measure of the stability of the PLS model. 
